glp 1 and inflammation GLP-1-based therapies, including GLP-1, GLP-1R agonists DPP-4 The anti-inflammatory feature of glucagon-like

In other words, it may make eating feel slightly less rewarding, which can help reduce the desire for food and emotional eating

In recent years, GLP-1 receptor agonists, have garnered significant attention for their potential benefits in heart failure management

[DOI] [PMC free article] [PubMed] [Google Scholar] 209.Castellana M., Cignarelli A., Brescia F., Perrini S., Natalicchio A., Laviola L

PubMed 4

The lateral parabrachial nucleus may be a critical site of action as pharmacological activation of GLP-Rs in the lateral parabrachial nucleus (LPBN) inhibits feeding whereas antagonism of LPBN GLP-1Rs induces hyperphagia (Alhadeff et al., The hypothalamus has also been implicated as a major center for mediating the pharmacological effects of GLP-1R action on energy metabolism

Across all these drugs, the common mechanism of action are glucose lowering via -cell GLP-1R, slowed gastric emptying (gut) and appetite suppression via central effects (McLean et al., 2021)